|
Endocrinology-metabolism / Original Article
Risk of atrial fibrillation in patients with differentiated thyroid cancer: a nationwide population-based analysis
Jung Heo, Seo Young Sohn, Yun Jin Kim, Sung Woo Cho
Korean J Intern Med. 2026;41(2):286-295. Published online March 1, 2026
Background/Aims: Thyroid hormone suppression therapy (THST) is widely used for long-term management of differentiated thyroid cancer (DTC). However, studies have suggested that THST may increase the risk of atrial fibrillation (AF) in patients with DTC. We aimed to evaluate whether the risk of AF in..
|